1

Elon Musk has hired two of his cousins to work at Twitter

 1 year ago
source link: https://finance.yahoo.com/news/elon-musk-hired-two-cousins-150000103.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.

Elon Musk has hired two of his cousins to work at Twitter

Sam Tabahriti,Kali Hays
Thu, December 8, 2022, 12:00 AM·2 min read
Elon Musk at the Met Gala.
Elon Musk has hired two of his cousins to work at Twitter.Andrew Kelly/Reuters
  • Elon Musk hired two cousins to work at Twitter, two people familiar with the matter told Insider.

  • Andrew Musk is working on software-engineering projects, while James Musk is "a fixer type."

  • Elon Musk took over Twitter in late October and has since laid off thousands of staff.

Elon Musk has hired family members to work at Twitter's San Francisco headquarters, two people familiar with the matter told Insider's Kali Hays.

His cousins James Musk and Andrew Musk – sons of the billionaire's uncle on his father's side – now appear to be full-time Twitter employees.

Andrew Musk works on software-engineering projects, while James Musk is more of as "a fixer type," helping Elon Musk on various tasks, one insider said.

The world's richest man has also brought in staff from his other companies, including engineers from Tesla and The Boring Company.

Others include his attorney Alex Spiro and his right-hand man Jared Birchall, who runs Musk's family office, Excession. They are among Musk confidantes who have been sleeping at Twitter's HQ after some office space was converted into bedrooms in light of his "hardcore" ultimatum.

San Francisco building inspectors are reportedly launching an investigation, according to a tweet from Ted Goldberg, a senior editor at KQED, San Francisco's public radio station. 

Since Elon Musk took over Twitter in late October, about 70% of the 7,500-strong workforce staff have been laid off, fired or resigned.

Representatives for both Twitter and the San Francisco Department of Building Inspection didn't immediately respond to requests for comment by Insider.

Are you a Twitter employee or someone else with insight to share? Use a nonwork device to contact Sam Tabahriti at [email protected] or Kali Hays at [email protected], on the secure messaging app Signal at 949-280-0267, or through Twitter DM at @hayskali

Read the original article on Business Insider

Recommended Stories
  • 803a174075653b6105f9350be6acb19a.cf.webp
    CNW Group

    CONFERENCE CALL FOR INVESTORS AND ANALYSTS

    Reconnaissance Energy Africa Ltd. (the "Company" or "ReconAfrica") (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) announces a conference call for investors and analysts will be held on Thursday, December 8, 2022 at 11:00 am Eastern Time. Participants will include Scot Evans, Chief Executive Officer, Dr. James Granath, Chief Geoscientist, and Grayson Andersen, Head of Capital Markets.

    7h ago
  • ce5f48e0-75a8-11ed-bffd-94da24d763f1.cf.webp
    Yahoo Finance Video

    Cannabis stocks slide after Senator McConnell rebukes marijuana legislation

    Yahoo Finance Live examines how Senator Mitch McConnell's rebuking of marijuana legislation may have impacted cannabis-tied stocks.

    1d ago
  • cb4b690d325dd8102d704a07d05bf229.cf.webp
    Zacks

    Mirati (MRTX) Down After 1st-Line Lung Cancer Data on Adagrasib

    Mirati Therapeutics' (MRTX) preliminary data from the first-line NSCLC study showed that adagrasib plus Merck's Keytruda achieved an objective response rate of 49%.

    5h ago
  • 810d5f8b8f49cb970d8737c57bf6b4a9.cf.webp
    Motley Fool

    Why Nio and Other Chinese EV Stocks Tanked Today

    Nio will need to show record monthly vehicle deliveries in December by a large margin to hit even the low end of its prior estimates.

    2h ago
  • c5e1e9f76ac05b83f769ee87498b9d07.cf.webp
    Motley Fool

    Why Carnival Stock Keeps Going Down

    This week has not been a fun time to own shares of Carnival (NYSE: CCL) (NYSE: CUK). Including today's 3.4% slide through 1 p.m. ET, Carnival stock has lost more than 10% of its value since the week began. On Tuesday, you see, investment banking heavyweight J.P. Morgan waded back into the cruise space with a trio of stock initiations.

    2h ago
  • 4e5d238c2437148d1b877f6a6571ddc9.cf.webp
    Motley Fool

    2 Bank Stocks to Buy Before the Bear Market Is Over

    All of the major indexes fell into bear market territory at various points this year with the Nasdaq Composite taking one of the bigger hits. Many Wall Street experts expect the bear market, or at the very least a correction, to stay with us well into 2023 as a recession looms. Analysts at Bank of America (NYSE: BAC) said the S&P 500 could fall to 3,240 by April, which would be a roughly 18% decline from current levels, before climbing back to around 4,000 by the end of the year -- which is essentially where it is now.

    5h ago
  • 931a8e2140e8a3f7b23f67e268ecf5d7.cf.webp
    Motley Fool

    Why MongoDB Stock Was Soaring Today

    Shares of MongoDB (NASDAQ: MDB) were flying higher today after the database software company posted strong results in its third-quarter earnings report. MongoDB, which specializes in NoSQL database software, trounced estimates in its latest update and even reported a surprise profit. Its cloud-based product, Atlas, again led the way with 61% growth and now makes up 63% of total revenue.

    3h ago
  • e1b8c920-7648-11ed-afb5-ea6dd464514d.cf.webp
    Yahoo Finance Video

    Costco earnings: What to expect on consumer spending, profits

    Yahoo Finance's Brian Sozzi previews expectations for Costco earnings.

    4h ago
  • 11b4d00e0a8c245581f6d56c2723a0df.cf.webp
    Benzinga

    Summit Therapeutics Shares Surge After Licensing Agreement For Cancer Program

    Akeso Inc announced a collaboration and license agreement with Summit Therapeutics Inc (NASDAQ: SMMT) to out-license its breakthrough bispecific antibody, ivonescimab (PD-1/VEGF, AK112) for development and commercialization in the U.S., Canada, Europe, and Japan. In addition, the company will co-brand the product in the license territories. Currently, Akeso is conducting a phase 3 trial of ivonescimab monotherapy versus pembrolizumab monotherapy as the first-line treatment for NSCLC patients wit

    1d ago
  • 990f6ec18562582654cd7b4bf5e75882.cf.webp
    Insider Monkey

    13 Best Gold Stocks To Buy For Recession

    In this article, we discuss the 13 best gold stocks to buy for recession. If you want to read about some more gold stocks, go directly to 5 Best Gold Stocks To Buy For Recession. According to a report by S&P Global, the sentiments for gold investment have risen over the past few months due […]

    6h ago
  • aa4ab1d7b62f21098ebff9ffae152617.cf.webp
    TipRanks

    Michael Burry sees recession looming — but that hasn’t stopped him from buying into these 2 stocks

    Worried about the prospect of a recession coming next year? Well, that sounds like a mild scenario, if Michael Burry’s prognosis is anything to go by. The investor whose famous bet against the US housing market was documented in “The Big Short,” thinks a ‘multi-year recession’ is potentially in the cards – and one more severe than currently expected. This statement follows previous warnings regarding the economy, such as predicting last year that the ‘mother of all crashes’ is coming, while also

    5h ago
  • 4f1a8d86cead9f96536efb147945dcc9.cf.webp
    Zacks

    Intel Corporation (INTC) is Attracting Investor Attention: Here is What You Should Know

    Intel (INTC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

    7h ago
  • b3d5e7d09f4fbee1a6d89488ced8fcc0.cf.webp
    Benzinga

    EXCLUSIVE: Anthony Scaramucci Calls Out Chamath Palihapitiya On FTX Warning Signs, 'We Can Pretend Otherwise, But None Of Us Really Knew'

    While speaking at Benzinga’s Future of Crypto event, investments in and by FTX were discussed as one of the biggest topics impacting the cryptocurrency sector. Kevin O’Leary was an investor in FTX and Anthony Scaramucci’s Skybridge Capital received an investment from FTX. Both shared their takeaways from the event of FTX and what happened with Sam Bankman-Fried. FTX Investments: Scaramucci said that many did not see warning signs with 25 of the greatest venture capitalists investing in FTX. Acco

    3h ago
  • 8659323d3eb6ac8c1e2e9241854f0fff.cf.webp
    Motley Fool

    Why Smith & Wesson Stock Misfired Today

    Smith & Wesson Brands (NASDAQ: SWBI) reported financial results that missed the target by a wide margin. After markets closed Tuesday, Smith & Wesson reported earnings of $0.26 per share on revenue of $121 million for its fiscal second quarter, which ended Oct. 31. The company blamed the macro environment for the miss, along with a difficult competitive environment.

    4h ago
  • bd091a0de04879d8006229fecdf07a2a.cf.webp
    Benzinga

    Esperion Therapeutics Reports Sooner Than Expected Positive Data From Nexletol Trial

    Esperion Therapeutics Inc's (NASDAQ: ESPR) CLEAR Outcomes trial met its primary endpoint, demonstrating statistically significant risk reduction in MACE-4 in patients treated with 180 mg/day NEXLETOL (bempedoic acid) compared to placebo. The data demonstrate statistically significant and clinically meaningful results. The study included over 14,000 patients at over 1,200 sites in 32 countries. Bempedoic acid becomes the first ATP citrate lyase inhibitor and oral non-statin to meet the major adve

    5h ago
  • b1235bf6d18ebc2cd7323427468d0693.cf.webp
    Simply Wall St.

    AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.48

    The board of AbbVie Inc. ( NYSE:ABBV ) has announced that it will be paying its dividend of $1.48 on the 15th of...

    7h ago
  • 804b92a3e1e5ccad4c86df54088abb23.cf.webp
    Motley Fool

    Why Devon Energy Stock Slumped 11% in November

    Shares of Devon Energy (NYSE: DVN) fell 11.4% in November, according to data provided by S&P Global Market Intelligence. The primary factor weighing on the oil stock was its third-quarter report, where the company unveiled a lower total dividend payment. Devon Energy launched the oil industry's first fixed-plus-variable dividend framework in early 2021.

    1d ago
  • 30827b71ab6a10cf270e3467ed35a5b6.cf.webp
    Motley Fool

    Why Zuora Stock Is Plunging Today

    Shares of Zuora (NYSE: ZUO), an online monetization platform company, were falling hard this morning after the company reported its results for the third quarter of its fiscal 2023, ended Oct. 31. While the company beat analysts' top- and bottom-line consensus estimate in the quarter, it issued weaker-than-expected fourth-quarter guidance and said that it was laying off 11% of its staff. Zuora reported a non-GAAP (adjusted) loss per share of $0.02 in the quarter, which was flat on a year-over-year basis but was better than Wall Street's average estimate of a loss of $0.06 per share.

    4h ago
  • 9h ago
  • 14e38d7781fc99d141066f1ec2596a6d.cf.webp
    SmartAsset

    I've Finally Retired! What Happens With My 401(k) Now?

    After retirement you can start withdrawing the money you have accumulated over the years in your 401(k). However, a number of rules govern retirees' 401(k) distributions. For instance, in most cases to avoid penalties you have to wait until after … Continue reading → The post How Does a 401(k) Work When You Retire? appeared first on SmartAsset Blog.

    7h ago
  • 09bea284c1858d4943cc7736c202e852.cf.webp
    Motley Fool

    Why United Natural Foods Stock Was Slumping Today

    Shares of United Natural Foods (NYSE: UNFI), the country's largest organic and natural food wholesaler, were pulling back today after the company issued a middling fiscal first-quarter earnings report. United Natural Foods said revenue in the quarter rose 7.6% to $7.53 billion, primarily driven by inflation and new business. The company also said it was implementing an industry-leading warehouse automation solution, which should help save on operating costs, and it also reduced its debt by $253 million by monetizing its accounts receivable.

    3h ago
  • 9f69c114c6fbe369db7aa62fd2600ec0.cf.webp
    Motley Fool

    Want $3,000 in Dividend Income Next Year? Invest $50,000 in These 2 Stocks

    Investors looking to boost their income often turn to high-yielding dividend stocks. If they invest in quality stocks, they can generate recurring revenue. If they invest in quality stocks that are currently trading at depressed valuations related to the bear market, they can also benefit from the stock price appreciation that is likely to occur going forward.

    10h ago
  • 315788027973556d56e125066929f1ad.cf.webp
    Fortune

    ‘Why do we allow this stuff?’ Jamie Dimon says investing in crypto tokens is like buying ‘pet rocks’

    The JPMorgan CEO has previously called cryptocurrencies dangerous, worthless and a “Ponzi scheme.”

    7h ago
  • b07a0405fc53377e891e2407991e0c53.cf.webp
    Motley Fool

    Why Ollie's Bargain Outlet Stock Was Falling Today

    Shares of Ollie's Bargain Outlet (NASDAQ: OLLI) were sliding today after the discount retailer missed estimates in its third-quarter earnings report. Ollie's, which offers deep discounts on name-brand closeout merchandise and excess inventory, said that comparable sales in the quarter rose 1.9%, and overall revenue increased 9% to $418.1 million, missing estimates at $429.1 million. Gross margin fell by 40 basis points to 39.4% due to higher supply chain costs and a slight decrease in merchandise margin, and overall operating margin declined 80 basis points to 7.1%.

    2h ago
  • 9ff30029efc8ff85cb2073aefafbe7ce.cf.webp
    MarketWatch

    BNP Paribas studied 100 years of market crashes — here’s what it says is coming next

    Whether Santa eventually comes or not is still to be determined, with Mr. Claus perhaps postponing a decision until next Tuesday’s CPI release. Strategists led by Greg Boutle, head of U.S. equity and derivatives strategy, are expecting a capitulation event next year. “This would be a departure from the current bear market regime, which has been characterized by a grind lower in equities as P/E multiples have contracted,” they say.

    9h ago
  • b4f5fdd49a380aea15480256ab1ca82d.cf.webp
    Motley Fool

    Warner Bros. Discovery Stock Has Been Left for Dead -- Is It Time to Buy?

    Warner Bros. Discovery (NASDAQ: WBD), formed earlier this year when telecom giant AT&T spun off WarnerMedia and merged it with Discovery, has all the makings of a media giant. The company's stable of intellectual property and assets is formidable: HBO, DC Comics, Warner Bros.' films, linear TV channels including CNN, TBS, TNT, Cartoon Network, HGTV, TLC, Discovery, and many more, and rights to broadcast NBA games all fall under the company's umbrella. Warner Bros. Discovery is also already a major player in streaming.

    8h ago
  • ace7df31c7fcb10255abe7c990ea373a.cf.webp
    Zacks

    Energy Transfer LP (ET) is Attracting Investor Attention: Here is What You Should Know

    Energy Transfer LP (ET) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

    7h ago
  • 4c9a0d60f0cc678900a0993803a907f9.cf.webp
    Motley Fool

    Why Lovesac Stock Was Falling Today

    Shares of Lovesac (NASDAQ: LOVE) were down 16% as of 11:40 a.m. ET on Wednesday after the company delivered better-than-expected earnings results for the fiscal third quarter ending Oct. 30. It was a strong quarter in the context of the economic environment. Lovesac clearly has a superior brand positioning and is taking significant market share.

    3h ago
  • fbcb1fb47846c704491b7cdca16e4528.cf.webp
    Simply Wall St.

    Is It Too Late To Consider Buying AMC Entertainment Holdings, Inc. (NYSE:AMC)?

    AMC Entertainment Holdings, Inc. ( NYSE:AMC ), is not the largest company out there, but it received a lot of attention...

    6h ago
  • cc3188ec12d315280e8da9e94df92c68.cf.webp
    Motley Fool

    Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money

    If you've got $2,000 to invest, here are three growth stocks to buy that could double your money. My Motley Fool colleague Prosper Junior Bakiny predicts that Axsome Therapeutics (NASDAQ: AXSM) stock could double in 2023. The company already has two products on the market.

    10h ago
  • 780a8e833768ba4ef3abbf0b34243a59.cf.webp
    Motley Fool

    Why Booking Holdings, Southwest Airlines, and Uber Fell Today

    Shares of Booking Holdings (NASDAQ: BKNG), Southwest Airlines (NYSE: LUV), and Uber (NYSE: UBER) all fell on Wednesday, down 3.5%, 3.6%, and 2.3%, respectively, as of 1:20 p.m. EST. As recession fears loom over the economy, it appears several analysts and investors are turning cautious on travel names toward year-end. With that much pessimism hanging over the economy, some analysts are downgrading travel names today despite the seemingly positive current picture.

    2h ago
  • 215b1d0e84c7df15b5d6f1a3b8e40443.cf.webp
    Investor's Business Daily

    Prometheus Bio 'Comfortably Overshoots' Drug's Expectations — And Shares Nearly Triple

    Prometheus Bio reported promising results from two inflammatory disease studies on Wednesday, and RXDX stock catapulted higher.

    2h ago
  • dbd3b30938cec396af4018f059582c5f.cf.webp
    Barrons.com

    Tesla Is Offering Discounts. Are Drivers Souring on Its Car?

    Bernstein's Toni Sacconaghi believes the electric vehicles company 'increasingly appears to have a demand issue.'

    58m ago
  • 430c20b6e7caf3c74ca7db431bd02074.cf.webp
    American City Business Journals

    GE buys out entire New York Times in first-ever advertising takeover, promoting new businesses

    General Electric, whose spinoff of its health care and energy companies will leave Evendale-based GE Aerospace as the sole company, bought out every single print add in the New York Times for the first time in the newspaper's history.

    1d ago
  • 36dfdfa1abbd0938fbd08a32d233fddf.cf.webp
    TipRanks

    Down More Than 40%: Deutsche Bank Says Buy These 2 Beaten-Down Stocks Before They Rebound

    Should investors prepare for a winter full of persistent headwinds? Inflation remains high, rising interest rates are putting a squeeze on capital as well as making consumer credit more expensive, and both the China COVID lockdowns and the Russian war in Ukraine continue to crimp global supply chains. But even though the markets are facing serious headwinds, not every stock is going to react by falling. According to the analysts at Wall Street giant Deutsche Bank, two interesting stocks are like

    20h ago
  • 3b5a5a2ffbaec8086cd68fb671038032.cf.webp
    The Wall Street Journal

    M&T Bank Stock Falls to Lowest Level Since 2021

    M Bank shares are down about 8%, set to close at their lowest level since 2021. The regional bank is Wednesday's worst performer in the S 500, according to Dow Jones Market Data. **What's spooking investors?** A new analyst report downgrading the stock from a bullish to neutral outlook, and a fourth-quarter investor update from the company. While the stock has outperformed the broader bank index substantially this year, a rockier road is ahead, said KBW analysts in a Tuesday note: + KBW's downgr

    3h ago
  • 647c834960d15c66330349c27b2ebca1.cf.webp
    Motley Fool

    Carnival Stock Is Down 54% -- 2 Reasons to Avoid It Like the Plague

    Down 54% year to date, Carnival (NYSE: CCL) stock has dropped substantially in 2022. And while that might garner the attention of bargain-hungry investors, it may pay to look before you leap at the shares.

    10h ago
  • 17a4db66bb13bdabcbf848550a6ea15a.cf.webp
    Zacks

    Why Is Axsome (AXSM) Up 18.6% Since Last Earnings Report?

    Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    4h ago
  • 0eb533076ca46f82d36134bbe792de64.cf.webp
    Benzinga

    Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis

    BTIG upgraded Aerovate Therapeutics Inc (NASDAQ: AVTE) from Neutral to Buy with a price target of $27. The analyst writes that to Aerovate's benefit, Gossamer Bio Inc's (NASDAQ: GOSS) TORREY Phase 2 results validated dry powder inhaled (DPI)-administered TKIs in pulmonary arterial hypertension (PAH) as a safe and technically viable approach. But Gossamer's DPI seralutinib does not look like a competitive disease-modifying therapy in PAH, with a PVR reduction of only 14% in the overall study popu

    1d ago
  • c5a9f61b16b7a924d748eb88195f5f05.cf.webp
    TheStreet.com

    You Won't Believe How Low Gasoline is Likely to Go

    Gasoline prices are falling sharply with the national average price targeting even more declines by Christmas.

    23h ago

About Joyk


Aggregate valuable and interesting links.
Joyk means Joy of geeK